The painting featured on the back cover is by Action for Safer Supply member millie. You can find more of millie's work at cherrymintrose.com. The zine design and layout is by Action for Safer Supply member Jonathan Valelly. Check out valelly.com to learn more about their work.

This zine is copyleft, meaning you are encouraged to reproduce it in part or in full. For instructions on how to access the PDF and/or print your own copies, see the last two pages.
 

Maamwi-Gka-Wiiji-Nokiimdimi: Working Together for Each Other - a webinar series organized by Anishinabek Nation, Oahas, and NSSCoP

- Webinar 1: Indigenous Harm Reduction 101 - introduction and basics

- Webinar 2: Ryan Joseph from Aamjwnaang First Nation and Betsy Kechego from Chippewas of the Thames First Nation share their journey through addiction and recovery. 

- Webinar 3: This webinar examines the intersection of Indigenous culture and traditions such as using traditional medicines or ceremonies with people who use drugs. Trevor Stratton (CAAN) talks about community readiness, community action, and wholistic care models for Indigenous PWUD. Cathy Walker of Giwaabamin who will discuss the importance of Plant Medicines and low barrier care options for PWUD who are street involved or unhoused.

Webinar 4: Explores the tapestry of Indigenous Harm Reduction movements within communities. 

A dynamic panel of folks shine a light on their local grassroots, community-led harm reduction initiatives. Discover the inspiring programs that have taken root, providing tangible examples of success that can be adapted and applied across diverse Indigenous communities. 

Webinar 5: Dr. Nanky Rai presents on Settler Colonialism and the Drug Poisoning Crisis - Structural Determinants of Overdose Deaths in so-called Canada; and Dr. Andrea Sereda presents Healing Through Change: How our healthcare system is failing vulnerable groups

VANDU. (2024). Living on the EIDGE - A VANDU Zine. DTES Drinkers Telling Our Own Stories. 

BCCDC. (2024).  Unregulated Drug Poisoning Emergency Dashboard. New information has been added to the dashboard as of April 12, 2024 on the use of prescribed alternatives to the toxic drug supply. 

Office of the Chief Medical Officer. (2024). Balancing Act: An All of Society Approach to Substance Use and Harms. 2023 Annual Report of the Chief Medical Officer of Health of Ontario to the Legislative Assembly of Ontario. Retrieved 04/12/2024 from https://www.ontario.ca/files/2024-04/moh-cmoh-annual-report-2023-en-2024-04-02.pdf 

CRACKDOWN Podcast: March episode - Kids on the block, part 3: Danny. 

Michaud, L., Kolla, G., Rudzinski, K., & Guta, A. (2024). Mapping a moral panic: News media narratives and medical expertise in public debates on safer supply, diversion, and youth drug use in Canada. International Journal of Drug Policy. 

Campbell, TJ., et al. (2024). Varying circumstances surrounding opioid toxicity deaths across ethno-racial groups in Ontario, Canada: a population-based descriptive cross-sectional study. BMJ Public Health

Ledlie, S., et al. (2024). Opioid-related deaths between 2019 and 2021 across 9 Canadian provinces and territories. Canadian Medical Association Journal. 

Kolla, G. et al. (2024). “Everybody is impacted. Everybody’s hurting”: Grief, loss, and the emotional impacts of overdose on harm reduction workers. International Journal of Drug Policy.  

- Harm reductions workers experience physical, emotional, and social effects from overdose related loss and grief. 

- This is exacerbated by the lack of political response to the scale of the crisis and the broader socio-economic-political environment of chronic underfunding for harm reduction services. 

- The study highlights opportunities for organizational practices to better support harm reduction workers. 

- Improvement to the socio-economic-political determinants of work are needed.

Dertadian, GC. (2024). The coloniality of drug prohibition. International Journal of Drug Policy. 

Russel, C., et al. (2024). Examining inequities in access to opioid agonist treatment (OAT) in take-home doses (THD): A Canadian OAT guideline synthesis and systematic review. International Journal of Drug Policy. 

Mayer, S., et al. (2024). “I’m just searching to get better”: Constructions of treatment citizenship on injectable opioid agonist treatment. Social Science and Medicine.

Watson, T.M., et al. (2024). Defining a public health approach to substance use: Perpsectives from professionals and practitioners across Canada. International Journal of Drug Policy.

Chen, X-Y. et al. (2024). Development of a fentanyl-specific monoclonal antibody (mAb) to antagonize pharmacological effects of fentanyl. Toxicology and Applied Pharmacology. 

Dertadian, GC., Askew, R., (2024). Towards a social harms approach in drug policy. International Journal of Drug Policy. 

Ivsins, A., et al. (2024). A qualitative study on perceptions and experiences of overdose among people who smoke drugs in Vancouver, British Columbia. Drug and Alcohol Dependence. 

Gozdzialski, L., et al. (2024). Beyond a spec: assessing heterogeneity in the unregulated opioid supply. Harm Reduction Journal. 

Pique-Buisan, J, Banos, Josep-E, Cabra-Badii, I. (2024). Telling the story of the opioid crisis: A narrative analysis of the TV series Dopesick. PLOS ONE

Sugarman, OK., et al. (2024). Association of buprenorphine retention and subsequent adverse outcomes following non-fatal overdose: An analysis using statewide linked Maryland databases. Drug and Alcohol Dependence. 

St. Onge, CM. et al. (2024). Xylazine does not enhance fentanyl reinforcement in rats: A behavioural economic analysis. Drug and Alcohol Dependence. 

Dunn, KE and Strain, EC. (2024). Establishing a research agenda for the study and assessment of opioid withdrawal. The Lancet Psychiatry. 

Collins, AB., et al. (2024). “It gets you high as a kite but not unsick”: Characterizations of and responses to a changing local drug supply by people who use drugs in Rhode Island. International Journal of Drug Policy. 

Kruis, NE., et al. (2024). Addiction Frameworks, Social Stigma, and NIMBY Syndrome: Examining Barriers to Responding to the Opioid Crisis. Contemporary Drug Problems. 

McAteer, JM. et al. (2024). NYC’s Overdose Prevention Centers: Data from the first year of supervised consumption services. NEJM Catalyst. 

Bovell-Ammon, BJ., et al. (2024). Prison Buprenorphine Implementation and Postrelease Opioid Use Disorder Outcomes. JAMA Network Open. 

Patocka, J. et al. (2024). Fentanyl and its derivatives: Pain-killers or man-killers? Heliyon. 

Johnson, B, Monwell, B., Johansson Capusan A. (2024). Long-acting injectable depot buprenorphine from a harm reduction perspective in patients with ongoing substance use and multiple psychiatric comorbidities: a qualitative interview study. Harm Reduction Journal. 

Victor, G., Ray, B., Watson, D. (2024). Use of harm reduction strategies by individuals with a history of incarceration: A short report using baseline data collected from the STAMINA clinical trial. Journal of Substance Use and Addiction Treatment. 

McClaren, R., et al., (2024). Differences in Substance Use and Harm Reduction Practices by Race and Ethnicity: Rhode Island Harm Reduction Surveillance System, 2021-2022. Journal of Public Health Management and Practice. 

Barry, R., et al. (2024). Prevalence of mental health disorders among individuals experiencing homelessness: A systematic review and meta-analysis. JAMA Psychiatry. 

Roy, BD., et al. (2024). Prescription opioid dispensing patterns among patients with schizophrenia or bipolar disorder. BMC Psychiatry. 

Lewer, D. et al. (2024). Fatal opioid overdoses during and shortly after hospital admissions in England: a case-crossover study. PLOS Medicine. 

Riggs, KR., Kertesz, SG. (2024). Illuminating the consequentialist logic of harm reduction after overdose through a hypothetical randomized trial. American Journal of Bioethics. 

Garcia-Sempere, A., et al. (2024). Initial opioid prescription characteristics and risk of opioid misuse, poisoning, and dependence: a retrospective cohort study. BMJ Quality and Safety. 

Schuler, MS., et al., (2024). Growing importance of high-volume buprenorphine prescriber in OUD treatment: 2009-2018. Drug and Alcohol Dependence. 

Baby, SM., et al., (2024). Fentanyl activates opposing opioid and non-opioid receptor systems that control breathing. Frontiers in Pharmacology.

Milas, BL., Varon, AJ. (2024). Naloxone for Opioid Overdose: Comment. Anesthesiology. 

Barnett, A., et al. (2024). The dynamics of more-than-human care in depot buprenorphine treatment: a new material analysis of Australian patients’ experiences. International Journal of Drug Policy. 

Popova, L., Massey, ZB., and Giordano, NA. (2024). Warning Labels as a Public Health Intervention: Effects and Challenges for Tobacco, Cannabis, and Opioid Medications. Annual Review of Public Health. 

• More than 1 in 4 deaths among young people in Canada were opioid-related in 2021, study finds
• Alberta, Ontario, Sask. announce partnership to create recovery-focused addictions treatment
• Into the unknown: a clear breakthrough, but an uncertain future for drug policy at the Commission on Narcotic Drugs
• The first goal of drug overdoses policy: Keep people alive
• Nearly 1 in 4 federal inmates are receiving treatment for opioid addiction
• Supervised consumption sites urgently needed, says study
• The emotional impacts of harm reduction work
• Opioids Came for Country Music. It’s Fighting Back. 
• Q & A: Are fears that young people are getting hooked on prescribed opioid a ‘moral panic’?

• British Columbia abruptly drops decriminalization after backlash
• B.C.’s retreat on drug decriminalization spurs concerns about fates of similar plans
• B.C. police seizures of medical opioids on the rise, causing concerns safer supply pills are being diverted
• B.C. to require hospitals have designated spaces for patient illicit drug use,  health minister says
• Contrasting studies show possible impact of safer supply in B.C.
• Drug decriminalization is not to blame for all our social woes
• Dr. Leslie Lappalainen: Keeping substance use out of B.C. hospitals. Here’s how
• How does B.C.’s safe supply program work - and is it being abused? 
• Scrutiny of B.C. drug decrim pilot program intensifies
• Overdose Crisis: A generation of B.C. children are losing their parents
• Managing withdrawal in hospital harder as street drugs get more potent: doctor
• Mixed reviews after BC significantly rolls back drug decriminalization

• Sask. Coroners Service reports 113 confirmed and suspected drug toxicity deaths from January to March
• Saskatoon’s Prairie Harm Reduction reduces operating hours
• New report shows astronomical increase of Sask. opioid deaths in first year of COVID pandemic

• Report says Winnipeg mobile overdose prevention site ‘surpasses all expectations’
• Manitoba opioid-related deaths increase fivefold between 2019-2021: report 
• Report recommends province establish multiple supervised consumption sites, offer safer drugs
• ‘Can’t keep letting fentanyl win’: Safe supply of drugs needed to fight Winnipeg’s crisis, says advocate
• Dangerous drugs circulating in Manitoba First Nation causing seizures

• Ontario is in the midst of a drug crisis. These seven charts show who’s being hit hardest 
• Toronto study finds race impacts opioid treatment 
• Ottawa extends 1-year lifeline to London safer opioid supply program 
• Paramedics now treating pain of opioid withdrawal to open door to recovery
• Fentanyl linked to 14 of 15 Windsor-area opioid overdoses during the past week
• Hamilton pilot adds safe use model in shelters to fight opioid deaths
• ‘There will be more lives needlessly lost’: high number of opioid-related deaths in northern Ontario
• Police chief wants more officers visible in Barrie’s opioid crisis
• Durham health launches new interactive tool to help fight opioid crisis
• Counterpoint: As parents, we support harm reduction in our community
• Overdoses, deaths prompt Haliburton, Kawartha Lakes, Northumberland Drug Strategy relaunch
• Reader letter: Windsor’s SafePoint ‘must be reopened immediately’

• Nearly 200 overdoses at Whitehorse shelter since 2020, inquest hears
• Darrell Taylor: Things were looking promising as my son tried to beat addiction, but were they really?

• Jordan Stephen from Cree Public Health talks about harm reduction in drugs related issues
• Quebec class action authorized against 16 pharma companies for role in opioid crisis